Highlights Novartis AG London S.E.

Equities

0QM7

CH0038459415

Delayed London S.E. Other stock markets 09:29:30 21/05/2018 pm IST			5-day change	1st Jan Change
76.86 ^CHF	-1.00%		-0.77%	-.--%

24/06	Foreign banks target Switzerland after UBS takeover of Credit Suisse	RE
24/06	NOVARTIS AG : Barclays reaffirms its Sell rating	ZD

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Foreign banks target Switzerland after UBS takeover of Credit Suisse	24/06	RE
Factbox-European companies cut jobs as economy sputters	21/06	RE
Dpa-AFX Overview: COMPANIES from 20/06/2024 - 15:15	20/06	DP
Novartis: towards the filing of a buyout offer for MorphoSys	20/06	CF
MorphoSys Set to Delist Following Acquisition by Novartis	20/06	MT
MorphoSys Inks Delisting Agreement After Takeover by Novartis	20/06	MT
Biotech company Morphosys will soon disappear from the stock exchange	20/06	RE
EU regulator mandates label updates on CAR-T cancer therapies	14/06	RE
PeptiDream and Novartis Agreement Becomes Effective with 28.3 Billion Yen Upfront Payment	14/06	MT
Novartis' Fabhalta Shows Promise in Addressing Critical Gaps in C3 Glomerulopathy Treatment	13/06	CI
Abu Dhabi, Novartis to Collaborate on Genomics Research for Cancer Therapy	07/06	MT
Novartis, Roche's Genentech Among Companies Facing Italian Competition Watchdog Inquiry Over Eye Drug	07/06	MT
Novartis and others face Italy antitrust probe over eye drug	06/06	RE
Three newcomers to the MDax - Rational, TUI and Traton move up	06/06	RE
Cytokinetics CEO Says Board Would Have Backed Actionable Buyout	05/06	DJ
NOVARTIS : UBS reiterates buy recommendation after ASCO	03/06	CF
Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes	02/06	RE
European Equities Close Higher in Friday Trading; Flash Euro Area Inflation Rises More Than Expected	31/05	MT
Swiss Market Index in the Green Amid US Rate Cut Optimism	31/05	MT
Novartis Says Late-Stage Scemblix Trial Meets Primary Endpoints	31/05	MT